Columbus Macro’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.06M Sell
21,927
-771
-3% -$108K 0.33% 96
2025
Q4
$2.79M Sell
22,698
-1,268
-5% -$154K 0.31% 101
2025
Q3
$2.66M Sell
23,966
-520
-2% -$59.1K 0.3% 102
2025
Q2
$2.71M Buy
24,486
+468
+2% +$49.8K 0.33% 97
2025
Q1
$2.69M Sell
24,018
-1,085
-4% -$112K 0.35% 99
2024
Q4
$2.32M Buy
25,103
+9,004
+56% +$811K 0.32% 106
2024
Q3
$1.35M Sell
16,099
-344
-2% -$26.2K 0.49% 73
2024
Q2
$1.13M Buy
16,443
+668
+4% +$44.6K 0.44% 82
2024
Q1
$1.16M Sell
15,775
-807
-5% -$62.1K 0.44% 80
2023
Q4
$1.36M Buy
+16,582
New +$1.29M 0.54% 67
2021
Q4
Sell
-19,881
Closed -$1.39M 168
2021
Q3
$1.39M Sell
19,881
-593
-3% -$41.7K 0.46% 68
2021
Q2
$1.41M Sell
20,474
-253
-1% -$16.9K 0.44% 68
2021
Q1
$1.34M Sell
20,727
-3,539
-15% -$228K 0.42% 69
2020
Q4
$1.41M Sell
24,266
-1,629
-6% -$98.3K 0.43% 66
2020
Q3
$1.64M Sell
25,895
-8,056
-24% -$559K 0.5% 65
2020
Q2
$2.61M Sell
33,951
-1,866
-5% -$143K 0.71% 45
2020
Q1
$2.68M Sell
35,817
-2,940
-8% -$203K 0.78% 38
2019
Q4
$2.52M Sell
38,757
-10,484
-21% -$683K 0.56% 53
2019
Q3
$3.12M Sell
49,241
-22,176
-31% -$1.45M 0.78% 48
2019
Q2
$4.83M Sell
71,417
-751
-1% -$49.4K 1.04% 37
2019
Q1
$4.69M Buy
72,168
+1,553
+2% +$103K 1.03% 41
2018
Q4
$4.42M Buy
70,615
+1,232
+2% +$86.1K 1.01% 40
2018
Q3
$5.36M Buy
69,383
+5,969
+9% +$451K 1.33% 26
2018
Q2
$4.49M Buy
+63,414
New +$4.48M 1.17% 34

Other funds holding GILD

Columbus Macro's GILD Position: Q1 2026 in Review

Columbus Macro reduced its Gilead Sciences (GILD) stake by 3.4% in Q1 2026, selling an estimated $108K and leaving 21,927 shares worth $3.06M. The position accounts for 0.33% of the portfolio, ranked #96.

Columbus Macro first reported a position in GILD in Q2 2018 and has held it in 24 quarters since. The position peaked at $5.36M in Q3 2018. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Columbus Macro held 21,927 shares of Gilead Sciences worth $3.06M as of Q1 2026.
  • Columbus Macro sold 771 Gilead Sciences shares in Q1 2026, an estimated $108K.
  • Gilead Sciences made up 0.33% of Columbus Macro's portfolio in Q1 2026, its #96 holding.
  • Columbus Macro first reported a position in Gilead Sciences in Q2 2018 and has held it in 24 quarters since.
  • Columbus Macro's Gilead Sciences position peaked at $5.36M in Q3 2018.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Columbus Macro's 13F filing for Q1 2026, filed 21 Apr 2026.